rolipram has been researched along with Movement Disorders in 2 studies
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giampà, C | 1 |
| Middei, S | 1 |
| Patassini, S | 1 |
| Borreca, A | 1 |
| Marullo, F | 1 |
| Laurenti, D | 1 |
| Bernardi, G | 1 |
| Ammassari-Teule, M | 1 |
| Fusco, FR | 1 |
| Dai, H | 1 |
| MacArthur, L | 1 |
| McAtee, M | 1 |
| Hockenbury, N | 1 |
| Tidwell, JL | 1 |
| McHugh, B | 1 |
| Mansfield, K | 1 |
| Finn, T | 1 |
| Hamers, FP | 1 |
| Bregman, BS | 1 |
2 other studies available for rolipram and Movement Disorders
| Article | Year |
|---|---|
Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease.
Topics: Analysis of Variance; Animals; Corpus Striatum; CREB-Binding Protein; Disease Models, Animal; Explor | 2009 |
Activity-based therapies to promote forelimb use after a cervical spinal cord injury.
Topics: Animals; Biotin; Cervical Vertebrae; Dextrans; Disease Models, Animal; Environment, Controlled; Exer | 2009 |